Tags

Type your tag names separated by a space and hit enter

6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
Arzneimittelforschung 1984; 34(6):716-20A

Abstract

79 patients suffering from peripheral arteriopathy (Fontaine's stage IIb) completed a 6-month double-blind randomised clinical trial of Ginkgo biloba extract (GBE) (as coated tablets containing 40 mg GBE; rökan) versus placebo in two parallel groups. From the results of measurements of pain-free walking distance, maximum walking distance and plethysmography recordings, GBE was shown to be active and significantly superior to placebo. These results correlated with the physician's and patients' overall assessment of response to treatment.

Authors

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

6386008

Citation

Bauer, U. "6-Month Double-blind Randomised Clinical Trial of Ginkgo Biloba Extract Versus Placebo in Two Parallel Groups in Patients Suffering From Peripheral Arterial Insufficiency." Arzneimittel-Forschung, vol. 34, no. 6, 1984, pp. 716-20.
Bauer U. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittelforschung. 1984;34(6):716-20.
Bauer, U. (1984). 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittel-Forschung, 34(6), pp. 716-20.
Bauer U. 6-Month Double-blind Randomised Clinical Trial of Ginkgo Biloba Extract Versus Placebo in Two Parallel Groups in Patients Suffering From Peripheral Arterial Insufficiency. Arzneimittelforschung. 1984;34(6):716-20. PubMed PMID: 6386008.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. A1 - Bauer,U, PY - 1984/1/1/pubmed PY - 1984/1/1/medline PY - 1984/1/1/entrez SP - 716 EP - 20 JF - Arzneimittel-Forschung JO - Arzneimittelforschung VL - 34 IS - 6 N2 - 79 patients suffering from peripheral arteriopathy (Fontaine's stage IIb) completed a 6-month double-blind randomised clinical trial of Ginkgo biloba extract (GBE) (as coated tablets containing 40 mg GBE; rökan) versus placebo in two parallel groups. From the results of measurements of pain-free walking distance, maximum walking distance and plethysmography recordings, GBE was shown to be active and significantly superior to placebo. These results correlated with the physician's and patients' overall assessment of response to treatment. SN - 0004-4172 UR - https://www.unboundmedicine.com/medline/citation/6386008/6_Month_double_blind_randomised_clinical_trial_of_Ginkgo_biloba_extract_versus_placebo_in_two_parallel_groups_in_patients_suffering_from_peripheral_arterial_insufficiency_ DB - PRIME DP - Unbound Medicine ER -